Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
Chromadex
Chromadex
Activities:
Ingredients
X
LinkedIn
Trending Articles
Symrise introduces health active solutions and concepts at Vitafoods Europe
The company will exhibit at booth D106, showcasing novel health active solutions that support gut health and immunity, healthy ageing and metabolic health
Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight
Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
The perfect pair: how vitamins K2 and D3 combine to support health and well-being
Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet...
Activ’Inside exhibit premium formulas and ready-for-market nutraceutical solutions at Vitafoods
The company will present premium ingredient solutions that promote joint and skin health
Market-first synbiotic combination to launch at Vitafoods Europe 2024
Clasado Biosciences has revealed that Vitafoods Europe 2024 will see the European debut of its market-first synbiotic offering, developed in partnership with Probi AB
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Ingredients
ChromaDex to supply healthy ageing ingredient for H&H Group
H&H Group will be licensed to use Chromadex’s nicotinamide riboside ingredient for products in its Swisse range
Ingredients
ChromaDex R&D facility earns ISO accreditation for ingredient testing
ISO/IEC 17025:2017 accreditation covers testing of the company's Tru Niagen consumer products, its Niagen ingredient, and phytochemical reference standards
Ingredients
Industry-first clinical trial on patent-protected nicotinamide riboside begins
The study will evaluate the impact of ChromaDex Corp's nicotinamide riboside supplementation to help tackle hypertension
Regulatory
ChromaDex receives 2 years market exclusivity for NR chloride ingredient
The nicotinamide riboside chloride ingredient has been approved for use in listed complementary medicines by the Australian Therapeutic Goods Administration
Ingredients
EFSA rules nicotinamide riboside is safe for consumption
The regulatory body has also found evidence to support the substance as a good source of vitamin B3
Research & Development
Animal study confirms that Pterostilbene can help reduce body fat and obesity
Could also reduce the risk of developing other diseases such as obesity
Subscribe now